Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|October 4, 2017
Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis PatientsKazuomi Yamashita, Sonoo Mizuiri, Yoshiko Nishizawa, et al.
Clinical and Experimental Nephrology|December 28, 2017
High-normal albuminuria and incident chronic kidney disease in a male nondiabetic populationAki Ashitani, Toshinori Ueno, Ayumu Nakashima, et al.
CEN Case Reports|June 9, 2017
Diffuse large B-cell lymphoma presenting as bilateral renal infiltration leading to acute kidney injuryTomoe Okubo, Shuma Hirashio, Minako Shimizu, et al.
Bone|March 9, 2004
Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levelsAyumu Nakashima, Noriaki Yorioka, Shigehiro Doi, et al.
Plos One|August 17, 2018
Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstructionKotaro Soji, Shigehiro Doi, Ayumu Nakashima, et al.
International Journal of Molecular Sciences|July 27, 2022
Upregulation of Mineralocorticoid Receptor Contributes to Development of Salt-Sensitive Hypertension after Ischemia-Reperfusion Injury in RatsTakumi Matsumoto, Shigehiro Doi, Ayumu Nakashima, et al.
Radiology|April 22, 2010
Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstructionOsamu Togao, Shigehiro Doi, Makoto Kuro-o, et al.
Plos One|August 12, 2016
Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in MiceTakuo Nagai, Shigehiro Doi, Ayumu Nakashima, et al.
Clinical and Experimental Nephrology|May 7, 2022
Relationships of hyperchloremia with hypertension and proteinuria in patients with chronic kidney diseaseAkira Takahashi, Kazuya Maeda, Kensuke Sasaki, et al.
Clinical Nephrology|April 28, 2018
Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case reportYumi Yamada, Toshinori Ueno, Taisuke Irifuku, et al.
Pageof 18